Endoscopic Surgery for Bariatric Revision After Weight Loss Failure
Primary Purpose
Morbid Obesity, Weight Loss
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Endoscopic Suturing to Create Early Satiety
Sponsored by
About this trial
This is an interventional treatment trial for Morbid Obesity focused on measuring Surgical Endoscopy, Morbid Obesity, Weight Loss, Bariatrics, Surgical Revision
Eligibility Criteria
Inclusion Criteria:
- Previous Roux-En-Y Gastric Bypass (RYGB) or Sleeve Gastrectomy (SG)
- Failure to lose >50% of their excess body weight after 1 year
- Failure of weight loss despite maximal medical therapy and medically-supervised diets
Exclusion Criteria:
- Esophageal Stricture
- Marginal Ulcer at the gastrojejunostomy anastomosis
- Non-compliance with bariatric follow-up
- Gastric ulcers
- Paraesophageal hernias
Sites / Locations
- University of California San Francisco
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Weight Gain
Arm Description
Patients who previously underwent bariatric surgery who failed to lose the expected weight or regained weight.
Outcomes
Primary Outcome Measures
Mean Weight Loss
We will track patient's weight after their endoscopic bariatric surgery.
Secondary Outcome Measures
Number of Participants With Resolved Co-morbidities
We will track the patient's weight loss and see if their obesity-related co-morbidities resolve.
Tolerance
We will be monitoring patient's tolerance to this procedure and evaluate their satisfaction via a short questionnaire.
Full Information
NCT ID
NCT01871896
First Posted
May 11, 2013
Last Updated
July 25, 2023
Sponsor
University of California, San Francisco
1. Study Identification
Unique Protocol Identification Number
NCT01871896
Brief Title
Endoscopic Surgery for Bariatric Revision After Weight Loss Failure
Official Title
Apollo OverStitch for Bariatric Surgery Revision After Weight Loss Failure
Study Type
Interventional
2. Study Status
Record Verification Date
July 2023
Overall Recruitment Status
Completed
Study Start Date
January 2014 (undefined)
Primary Completion Date
June 2022 (Actual)
Study Completion Date
June 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of California, San Francisco
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Morbid obesity and its associated metabolic diseases are on the rise in the United States. Currently, the best treatment for obesity is bariatric surgery where both roux-en-Y gastric bypass and sleeve gastrectomy offer substantial weight loss. Unfortunately, 20% of patients who undergo bariatric surgery fail to lose enough weight defined as less than 50% of excess body weight loss or regain of weight. For those patients who fail to lose weight after bariatric surgery and have failed maximal medical therapy and diet supervision, the treatment is re-operation and revision. Re-operation of the abdomen carries significant postoperative morbidity and mortality. The investigators propose to use the Apollo OverStitch endoscopic suturing device that has already been approved by the FDA as an option for bariatric surgery revision without having to re-operate on the patient. The investigators believe that the endoscopic technique may be able to provide weight loss without having to re-operate on the patient.
Detailed Description
The most effective weight loss procedures in the United States are both roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG)where the majority are performed laparoscopically. Estimated excess body weight loss (EBWL) is >50% at the end of one year. However, nearly 20% of patients fail to meet the estimated EBWL or they may experience weight gain recidivism. The first step is nutritional counseling, medically supervised diets, and medical therapy. Surgery would be for those who still fail to lose weight despite the aforementioned efforts.
It is hypothesized that failure of weight loss for RYGB is gastrojejunostomy (GJ) dilation defined as >2 cm. Surgical treatment would require revision of this dilation. Unfortunately many of these revision procedures cannot be done laparoscopically given dense intra-abdominal adhesions. This will require conversion to an open surgery in a morbidly obese patient thus raising postoperative morbidity and mortality estimated to range between 15%-50%.
The investigators propose to use the endoscopic suturing device designed by Apollo EndoSurgery to decrease the GJ dilation to 5-6 mm thus causing restriction, delayed food transit time, and promote early satiety. These efforts will limit overall caloric intake thereby promoting weight loss.
It is thought that patients with previous SG may have a dilation of their stomach. The investigators propose a pyloric cerclage using the Apollo EndoSurgery suturing device by decreasing the opening of the pylorus thus achieving the same goals that the investigators proposed above with RYGB revision.
Endoscopic procedures are same day procedures with little morbidity and mortality when compared to laparoscopic or open bariatric surgery revision.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Morbid Obesity, Weight Loss
Keywords
Surgical Endoscopy, Morbid Obesity, Weight Loss, Bariatrics, Surgical Revision
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
24 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Weight Gain
Arm Type
Experimental
Arm Description
Patients who previously underwent bariatric surgery who failed to lose the expected weight or regained weight.
Intervention Type
Device
Intervention Name(s)
Endoscopic Suturing to Create Early Satiety
Other Intervention Name(s)
Endoscopic Cerclage, Bariatric Surgery Revision, Apollo EndoStitch, Apollo OverTube
Intervention Description
Evaluating the efficacy of endoscopic suturing for weight loss.
Primary Outcome Measure Information:
Title
Mean Weight Loss
Description
We will track patient's weight after their endoscopic bariatric surgery.
Time Frame
3 months after procedure
Secondary Outcome Measure Information:
Title
Number of Participants With Resolved Co-morbidities
Description
We will track the patient's weight loss and see if their obesity-related co-morbidities resolve.
Time Frame
2 years
Title
Tolerance
Description
We will be monitoring patient's tolerance to this procedure and evaluate their satisfaction via a short questionnaire.
Time Frame
2 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Previous Roux-En-Y Gastric Bypass (RYGB) or Sleeve Gastrectomy (SG)
Failure to lose >50% of their excess body weight after 1 year
Failure of weight loss despite maximal medical therapy and medically-supervised diets
Exclusion Criteria:
Esophageal Stricture
Marginal Ulcer at the gastrojejunostomy anastomosis
Non-compliance with bariatric follow-up
Gastric ulcers
Paraesophageal hernias
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stanley J Rogers, MD
Organizational Affiliation
University of California, San Francisco
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jonathan T Carter, MD
Organizational Affiliation
University of California, San Francisco
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
John P Cello, MD
Organizational Affiliation
University of California, San Francisco
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Matthew Lin, MD
Organizational Affiliation
University of California, San Francisco
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of California San Francisco
City
San Francisco
State/Province
California
ZIP/Postal Code
94143
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
23567348
Citation
Thompson CC, Chand B, Chen YK, DeMarco DC, Miller L, Schweitzer M, Rothstein RI, Lautz DB, Slattery J, Ryan MB, Brethauer S, Schauer P, Mitchell MC, Starpoli A, Haber GB, Catalano MF, Edmundowicz S, Fagnant AM, Kaplan LM, Roslin MS. Endoscopic suturing for transoral outlet reduction increases weight loss after Roux-en-Y gastric bypass surgery. Gastroenterology. 2013 Jul;145(1):129-137.e3. doi: 10.1053/j.gastro.2013.04.002. Epub 2013 Apr 5.
Results Reference
background
PubMed Identifier
22258299
Citation
Deylgat B, D'Hondt M, Pottel H, Vansteenkiste F, Van Rooy F, Devriendt D. Indications, safety, and feasibility of conversion of failed bariatric surgery to Roux-en-Y gastric bypass: a retrospective comparative study with primary laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2012 Jul;26(7):1997-2002. doi: 10.1007/s00464-011-2140-0. Epub 2012 Jan 19.
Results Reference
background
PubMed Identifier
22054158
Citation
Kellogg TA. Revisional bariatric surgery. Surg Clin North Am. 2011 Dec;91(6):1353-71, x. doi: 10.1016/j.suc.2011.08.004.
Results Reference
background
PubMed Identifier
21902955
Citation
deWolfe MA, Bower CE. Using the StomaphyX(TM) endoplicator to treat a gastric bypass complication. JSLS. 2011 Jan-Mar;15(1):109-13. doi: 10.4293/108680811X13022985131570.
Results Reference
background
PubMed Identifier
21640665
Citation
Thompson CC, Jacobsen GR, Schroder GL, Horgan S. Stoma size critical to 12-month outcomes in endoscopic suturing for gastric bypass repair. Surg Obes Relat Dis. 2012 May-Jun;8(3):282-7. doi: 10.1016/j.soard.2011.03.014. Epub 2011 Apr 19.
Results Reference
background
PubMed Identifier
21474389
Citation
Raman SR, Holover S, Garber S. Endolumenal revision obesity surgery results in weight loss and closure of gastric-gastric fistula. Surg Obes Relat Dis. 2011 May-Jun;7(3):304-8. doi: 10.1016/j.soard.2011.01.045. Epub 2011 Feb 22.
Results Reference
background
PubMed Identifier
22055390
Citation
Heneghan HM, Yimcharoen P, Brethauer SA, Kroh M, Chand B. Influence of pouch and stoma size on weight loss after gastric bypass. Surg Obes Relat Dis. 2012 Jul-Aug;8(4):408-15. doi: 10.1016/j.soard.2011.09.010. Epub 2011 Sep 23.
Results Reference
background
PubMed Identifier
21533520
Citation
Yimcharoen P, Heneghan HM, Singh M, Brethauer S, Schauer P, Rogula T, Kroh M, Chand B. Endoscopic findings and outcomes of revisional procedures for patients with weight recidivism after gastric bypass. Surg Endosc. 2011 Oct;25(10):3345-52. doi: 10.1007/s00464-011-1723-0. Epub 2011 Apr 30.
Results Reference
background
Learn more about this trial
Endoscopic Surgery for Bariatric Revision After Weight Loss Failure
We'll reach out to this number within 24 hrs